For example, low doses of an anti-VEGFR-2 blocker that increased tumor perfusion induced an immunocompetent tumor microenvironment characterized by CD8+ T lymphocytes and anti-tumorigenic M1 tumor associated macrophages infiltration [75]. This evidence concerns the gene CD8A and neoplasm.